3 completed, 1 not yet recruiting, 1 recruiting. 2 Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Arthritic Psoriasis: new trials by email Literature Review of Arthritic Psoriasis trials Research Report on Arthritic Psoriasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Retinal Capillary Vessel Density and Foveal Avascular Zone Size in Patients With Psoriatic Arthritis: A Case-Control Study. OCTA-SCP, OCTA-DCP, OCTA-RPC - Arthritic Psoriasis, Psoriasis (PsO) | Recruiting | Bursa Yuksek Ihtisas Training and Research Hospital | 135 | 2026-09-01 | 2026-10-13 | |
| Oral CBP-0276 or Placebo in Adults With Active Psoriatic Arthritis (PsA) CBP-0276 capsules 100mg, Placebo - Arthritic Psoriasis | Phase 2 | Not yet recruiting | Clarent Biopharma, Inc. | 240 | 2026-07-01 | 2026-07-16 |
| A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation BMS-986165 Capsule, BMS-986165 Tablet - Systemic Lupus Erythematosus, Arthritic Psoriasis | Phase 1 | Completed | Bristol-Myers Squibb | 49 | 2017-09-13 | 2020-02-25 |
| The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients BMS-986165, Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 μg ethinyl estradiol) - Systemic Lupus Erythematosus, Arthritic Psoriasis | Phase 1 | Completed | Bristol-Myers Squibb | 49 | 2017-09-01 | 2020-03-19 |
| Evaluation of Adipokines and Fat Tissue in Psoriasis and Psoriatic Arthritis bone densitometry, questionnaires, biological analyses - Psoriasis, Arthritic Psoriasis | Not applicable | Completed | Centre Hospitalier Universitaire de Besancon | 199 | 2014-04-01 | 2018-02-12 |
Arthritis, Psoriatic (5) · Psoriasis (4) · Inflammatory Bowel Diseases (2) · Lupus Erythematosus, Systemic (2) · Obesity, Abdominal (1)
Arthritis (5) · Bone Diseases (5) · Joint Diseases (5) · Musculoskeletal Diseases (5) · Skin Diseases (5) · Skin Diseases, Papulosquamous (5) · Skin and Connective Tissue Diseases (5) · Spinal Diseases (5) · Spondylarthritis (5) · Spondylarthropathies (5) · Spondylitis (5) · Autoimmune Diseases (2) · Connective Tissue Diseases (2) · Digestive System Diseases (2) · Gastroenteritis (2)
deucravacitinib (2) · Biological Oxygen Demand Analysis (1) · Surveys and Questionnaires (1)
Bristol-Myers Squibb (2) · Bursa Yuksek Ihtisas Training and Research Hospital (1) · Centre Hospitalier Universitaire de Besancon (1) · Clarent Biopharma, Inc. (1)
United States (2) · France (1) · Mexico (1) · Turkey (Türkiye) (1)